<p>Representative photographs of PAS-stained glomerular and tubular regions noticed in control mice (Sham, A, B), and 7 (C, D), 14 (E, F) and 21 (G, H) days after injection of adriamycin (10 mg/kg). Glomerular damage (large arrows), tubule-interstitial changes, atrophy of tubular epithelial cells (arrowheads) and tubular enlargement (thin arrows, insert) increased in the renal cortex from day 7 (D) to day 14 (F, insert, arrow). Global sclerosis was observed in many glomeruli (E, asterisks). Resorption droplets were present in tubular cells at day 14 (panel F, thin arrows). Histological changes stabilized on day 21 (G, H). Original magnification 40× objective.</p
<p>BALB/c mice were injected at day 0 with 10 mg/kg of adriamycin (ADM) or treated concomitantly wit...
<p>Masson’s trichrome staining was performed to determine levels of histologic injury in the mice at...
Adriamycin (doxorubicin), a common cancer chemotherapeutic drug, can be used to induce a model of ch...
<p>Kidneys were collected for morphological analysis at day 12 after adriamycin induced nephropathy....
<p>Adriamycin (10 mg/kg) was injected in tail vein of Balb/c mice, on day 0 in vehicle-treated, VE (...
Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Serial changes ...
<p><i>wt</i> or <i>hpa</i>-TG mice were injected with Adriamycin (ADR) or served as control (sham). ...
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. The present study was...
<p>Interstitial α-SMA increased progressively in proteinuric kidneys during follow up (A, B). α-SMA ...
<p>Adriamycin (10 mg/kg) was injected in the tail vein of Mas<sup>+/+</sup> (A–D) and Mas<sup>−/−</s...
Background. The renal minimal lesion disease induced in rats by adriamycin (ADR) is generally though...
Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events.Ba...
Background. Antioxidant enzyme status changes in experimental models of chronic renal disease with g...
Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Serial changes ...
<p>The podocytes were treated with Adriamycin (20 μg/ml) for different times. The expression levels ...
<p>BALB/c mice were injected at day 0 with 10 mg/kg of adriamycin (ADM) or treated concomitantly wit...
<p>Masson’s trichrome staining was performed to determine levels of histologic injury in the mice at...
Adriamycin (doxorubicin), a common cancer chemotherapeutic drug, can be used to induce a model of ch...
<p>Kidneys were collected for morphological analysis at day 12 after adriamycin induced nephropathy....
<p>Adriamycin (10 mg/kg) was injected in tail vein of Balb/c mice, on day 0 in vehicle-treated, VE (...
Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Serial changes ...
<p><i>wt</i> or <i>hpa</i>-TG mice were injected with Adriamycin (ADR) or served as control (sham). ...
Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. The present study was...
<p>Interstitial α-SMA increased progressively in proteinuric kidneys during follow up (A, B). α-SMA ...
<p>Adriamycin (10 mg/kg) was injected in the tail vein of Mas<sup>+/+</sup> (A–D) and Mas<sup>−/−</s...
Background. The renal minimal lesion disease induced in rats by adriamycin (ADR) is generally though...
Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events.Ba...
Background. Antioxidant enzyme status changes in experimental models of chronic renal disease with g...
Adriamycin-induced nephropathy as a model of chronic progressive glomerular disease. Serial changes ...
<p>The podocytes were treated with Adriamycin (20 μg/ml) for different times. The expression levels ...
<p>BALB/c mice were injected at day 0 with 10 mg/kg of adriamycin (ADM) or treated concomitantly wit...
<p>Masson’s trichrome staining was performed to determine levels of histologic injury in the mice at...
Adriamycin (doxorubicin), a common cancer chemotherapeutic drug, can be used to induce a model of ch...